Clinical Pharmaceutical Chemistry
Table of contents
Research group description
As according to the principles of clinical pharmaceutical chemistry, in our view of medical phenomena, the human body is seen as the reaction vessel and molecular transformations are used to interpret disease mechanisms and progression via chemical reactions. Chemical reactions between functional groups, atoms and molecules offer the deepest achievable level of examining human body functions and are thus superior in interpreting any clinically seen changes or transformations in patients.
The therapy areas which we mostly work in are oncology (solid tumours), hemato-oncology (hematologic malignancies), HIV, Hepatitis C, and addiction medicine.
To complement our strong clinical and translational research, we also investigate
- psychosocial support methods and resources of cancer patients and
- digital tools to improve patient monitoring and involvement in clinical trials, and equal care regardless of geographic distances.
In addition, our group uses the wide capabilities of Finnish data lakes, electronic structural health records and the Finnish Biobank Network samples to conduct complex retrospective clinical and biomarker studies that can even replace slowly evolving prospective studies.
We currently run both public and pharmaceutical industry funded research projects, as well as jointly funded projects (academia + industry).